BIOMARIN PHARMACEUTICAL COM STK USD0.001BIOMARIN PHARMACEUTICAL COM STK USD0.001BIOMARIN PHARMACEUTICAL COM STK USD0.001

BIOMARIN PHARMACEUTICAL COM STK USD0.001

No trades
See on Supercharts
Market capitalization
‪17.47 B‬USD
‪167.65 M‬USD
‪2.42 B‬USD
‪185.93 M‬
Beta (1Y)
0.38

About BIOMARIN PHARMACEUTICAL COM STK USD0.001

CEO
Alexander Hardy
Headquarters
San Rafael
Employees (FY)
‪3.4 K‬
Founded
1997
FIGI
BBG00JRQRV85
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 0HNC is featured.

Frequently Asked Questions

The current price of 0HNC is 91.54 USD — it has decreased by 0.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BIOMARIN PHARMACEUTICAL COM STK USD0.001 stocks are traded under the ticker 0HNC.
BIOMARIN PHARMACEUTICAL COM STK USD0.001 is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
0HNC stock is 1.49% volatile and has beta coefficient of 0.38. Check out the list of the most volatile stocks — is BIOMARIN PHARMACEUTICAL COM STK USD0.001 there?
0HNC earnings for the last quarter are 0.11 USD per share, whereas the estimation was 0.20 USD resulting in a −43.74% surprise. The estimated earnings for the next quarter are 0.32 USD per share. See more details about BIOMARIN PHARMACEUTICAL COM STK USD0.001 earnings.
BIOMARIN PHARMACEUTICAL COM STK USD0.001 revenue for the last quarter amounts to ‪646.21 M‬ USD despite the estimated figure of ‪638.82 M‬ USD. In the next quarter revenue is expected to reach ‪651.30 M‬ USD.
Yes, you can track BIOMARIN PHARMACEUTICAL COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
0HNC stock has risen by 0.72% compared to the previous week, the month change is a 7.88% rise, over the last year BIOMARIN PHARMACEUTICAL COM STK USD0.001 has showed a 5.04% decrease.
0HNC net income for the last quarter is ‪20.38 M‬ USD, while the quarter before that showed ‪40.38 M‬ USD of net income which accounts for −49.54% change. Track more BIOMARIN PHARMACEUTICAL COM STK USD0.001 financial stats to get the full picture.
Today BIOMARIN PHARMACEUTICAL COM STK USD0.001 has the market capitalization of ‪17.47 B‬, it has decreased by 1.52% over the last week.
No, 0HNC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0HNC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARIN PHARMACEUTICAL COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
0HNC reached its all-time high on Jul 22, 2020 with the price of 126.86 USD, and its all-time low was 68.84 USD and was reached on Oct 22, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪3.40 K‬ employees. See our rating of the largest employees — is BIOMARIN PHARMACEUTICAL COM STK USD0.001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOMARIN PHARMACEUTICAL COM STK USD0.001 technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOMARIN PHARMACEUTICAL COM STK USD0.001 stock shows the buy signal. See more of BIOMARIN PHARMACEUTICAL COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOMARIN PHARMACEUTICAL COM STK USD0.001 future price: according to them, 0HNC price has a max estimate of 140.00 USD and a min estimate of 80.00 USD. Read a more detailed BIOMARIN PHARMACEUTICAL COM STK USD0.001 forecast: see what analysts think of BIOMARIN PHARMACEUTICAL COM STK USD0.001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARIN PHARMACEUTICAL COM STK USD0.001 EBITDA is ‪298.12 M‬ USD, and current EBITDA margin is 12.35%. See more stats in BIOMARIN PHARMACEUTICAL COM STK USD0.001 financial statements.